<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Domperidone, a "hidden" <z:chebi fb="25" ids="35476">neuroleptic</z:chebi>, is used for symptomatic treatment of <z:hpo ids='HP_0002020'>gastroesophageal reflux disease</z:hpo>, despite its uncertain efficacy </plain></SENT>
<SENT sid="1" pm="."><plain>The intravenous form was withdrawn from the market in the 1980s following <z:hpo ids='HP_0011420'>deaths</z:hpo> due to <z:hpo ids='HP_0011675'>cardiac arrhythmias</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>QT prolongation leading to <z:hpo ids='HP_0011675'>cardiac arrhythmias</z:hpo>, including life-threatening <z:hpo ids='HP_0001664'>torsades de pointes</z:hpo>, has also been attributed to oral domperidone </plain></SENT>
<SENT sid="3" pm="."><plain>In 2010, two case-control studies, one Canadian and one Dutch, showed that patients who died suddenly or had severe <z:hpo ids='HP_0004308'>ventricular arrhythmias</z:hpo> were statistically significantly more likely than controls to have been exposed to domperidone </plain></SENT>
<SENT sid="4" pm="."><plain>In practice, given its uncertain efficacy and a disproportionate risk of <z:hpo ids='HP_0001699'>sudden death</z:hpo> and severe <z:hpo ids='HP_0004308'>ventricular arrhythmia</z:hpo>, domperidone should not be used </plain></SENT>
</text></document>